Literature DB >> 17372355

Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.

Manashi Sherawat1, Punit Kaur, Markus Perbandt, Christian Betzel, William A Slusarchyk, Gregory S Bisacchi, Chiehying Chang, Bruce L Jacobson, Howard M Einspahr, Tej P Singh.   

Abstract

The structure of the complex formed between bovine beta-trypsin and the highly potent synthetic inhibitor 2-{3'-[5'-methoxy-2'-(N-p-diaminomethylphenyl)amido]-1'-pyrido}-5-(N-2''-t-butylethanol)amidobenzoic acid (C(28)H(32)N(5)O(6)) has been determined at 0.97 A resolution. X-ray intensity data were collected to 0.97 A under cryocooled conditions. The structure was refined anisotropically using REFMAC5 and SHELX-97 to R(cryst) factors of 13.4 and 12.6% and R(free) factors of 15.7 and 16.3%, respectively. Several regions of the main chain and side chains that have not been previously observed were clearly defined in the present structure. H atoms are indicated as significant peaks in an |F(o) - F(c)| difference map, which accounts for an estimated 35% of all H atoms at the 2.5sigma level. The C, N and O atoms are definitively differentiated in the electron-density maps. The amido part of the inhibitor occupies the specificity pocket and the remainder fills the remaining part of the ligand-binding cleft and interacts with the enzyme through an extensive network of hydrogen bonds. The inhibitor distorts the stereochemistry of the catalytic triad, Ser195-His57-Asp102, thereby blocking the proton-relay process of the active site by preventing the formation of the crucial hydrogen bond between His57 N(delta1) and Asp102 O(delta1).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372355     DOI: 10.1107/S090744490700697X

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  4 in total

1.  High-resolution structure of the recombinant sweet-tasting protein thaumatin I.

Authors:  Tetsuya Masuda; Keisuke Ohta; Bunzo Mikami; Naofumi Kitabatake
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-24

2.  Evaluation of docking performance in a blinded virtual screening of fragment-like trypsin inhibitors.

Authors:  Georgiana Surpateanu; Bogdan I Iorga
Journal:  J Comput Aided Mol Des       Date:  2011-12-17       Impact factor: 3.686

3.  Detection of protein catalytic residues at high precision using local network properties.

Authors:  Patrick Slama; Ioannis Filippis; Michael Lappe
Journal:  BMC Bioinformatics       Date:  2008-12-04       Impact factor: 3.169

4.  PharmDock: a pharmacophore-based docking program.

Authors:  Bingjie Hu; Markus A Lill
Journal:  J Cheminform       Date:  2014-04-16       Impact factor: 5.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.